Home / Inspections / 1067044

FDA Inspection 1067044 — Lonza Walkersville, Inc.

Lonza Walkersville, Inc. — FEI 1114298

The FDA completed an inspection of Lonza Walkersville, Inc. on July 26, 2018 in Walkersville, MD. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
July 26, 2018
Fiscal Year
2018
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Walkersville, MD (United States)

Facility

Other inspections at this facility

  • 1307068 (NAI Tue Mar 24 2026 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1156019 (VAI Fri Nov 05 2021 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1058040 (VAI Tue Jul 03 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1000705 (OAI Mon Feb 06 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 991587 (VAI Thu Jun 09 2016 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources